(SLAB) Silicon Laboratories - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8269191024
Stock: Microcontrollers, Sensors, IoT, Wireless, Mixed-Signal
Total Rating 44
Risk 86
Buy Signal -1.28
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 124% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.82 |
| Alpha | 25.55 |
| Character TTM | |
|---|---|
| Beta | 1.765 |
| Beta Downside | 2.121 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.35% |
| CAGR/Max DD | 0.08 |
Description: SLAB Silicon Laboratories January 09, 2026
Silicon Laboratories (NASDAQ: SLAB) is a fabless semiconductor firm that designs analog-intensive mixed-signal solutions, notably wireless microcontrollers and sensor products, for a broad spectrum of industrial and commercial IoT applications-from smart-home cameras and HVAC controls to electric-vehicle charging stations and medical wearables.
In its most recent fiscal year (2023) the company reported revenue of roughly $1.0 billion, a year-over-year increase of about 10 % driven by strong demand for low-power connectivity chips in the industrial IoT segment; gross margins stayed near 55 % while operating cash flow exceeded $300 million, reflecting disciplined cost management. Key macro drivers include the U.S. CHIPS Act-funded expansion of domestic semiconductor capacity and the accelerating adoption of 5G-enabled edge devices, both of which underpin the long-term growth outlook for mixed-signal components.
If you’re looking to deepen your quantitative analysis, a quick look at ValueRay’s detailed valuation models for SLAB could surface additional upside scenarios worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -86.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 7.24 > 1.0 |
| NWC/Revenue: 68.29% < 20% (prev 98.19%; Δ -29.90% < -1%) |
| CFO/TA 0.08 > 3% & CFO 97.5m > Net Income -86.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.8m) vs 12m ago 1.63% < -2% |
| Gross Margin: 55.89% > 18% (prev 0.54%; Δ 5535 % > 0.5%) |
| Asset Turnover: 59.37% > 50% (prev 40.42%; Δ 18.95% > 0%) |
| Interest Coverage Ratio: -80.80 > 6 (EBITDA TTM -41.0m / Interest Expense TTM 1.02m) |
Altman Z'' 10.00
| A: 0.40 (Total Current Assets 652.6m - Total Current Liabilities 145.3m) / Total Assets 1.25b |
| B: 0.75 (Retained Earnings 939.5m / Total Assets 1.25b) |
| C: -0.07 (EBIT TTM -82.5m / Avg Total Assets 1.25b) |
| D: 5.15 (Book Value of Equity 939.7m / Total Liabilities 182.4m) |
| Altman-Z'' Score: 10.07 = AAA |
Beneish M -2.96
| DSRI: 0.94 (Receivables 67.3m/48.9m, Revenue 742.8m/505.0m) |
| GMI: 0.96 (GM 55.89% / 53.88%) |
| AQI: 0.94 (AQ_t 0.38 / AQ_t-1 0.40) |
| SGI: 1.47 (Revenue 742.8m / 505.0m) |
| TATA: -0.15 (NI -86.0m - CFO 97.5m) / TA 1.25b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of SLAB shares?
As of February 05, 2026, the stock is trading at USD 203.41 with a total of 8,442,454 shares traded.
Over the past week, the price has changed by +41.02%, over one month by +47.47%, over three months by +60.46% and over the past year by +48.91%.
Over the past week, the price has changed by +41.02%, over one month by +47.47%, over three months by +60.46% and over the past year by +48.91%.
Is SLAB a buy, sell or hold?
Silicon Laboratories has received a consensus analysts rating of 3.73.
Therefor, it is recommend to hold SLAB.
- StrongBuy: 3
- Buy: 2
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SLAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 152.2 | -25.2% |
| Analysts Target Price | 152.2 | -25.2% |
| ValueRay Target Price | 139.1 | -31.6% |
SLAB Fundamental Data Overview February 05, 2026
P/E Forward = 52.0833
P/S = 6.2145
P/B = 4.3144
P/EG = 3.0343
Revenue TTM = 742.8m USD
EBIT TTM = -82.5m USD
EBITDA TTM = -41.0m USD
Long Term Debt = 15.5m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = unknown (none)
Debt = 15.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -341.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.29b USD (4.62b + Debt 15.5m - CCE 341.4m)
Interest Coverage Ratio = -80.80 (Ebit TTM -82.5m / Interest Expense TTM 1.02m)
EV/FCF = 58.31x (Enterprise Value 4.29b / FCF TTM 73.6m)
FCF Yield = 1.72% (FCF TTM 73.6m / Enterprise Value 4.29b)
FCF Margin = 9.91% (FCF TTM 73.6m / Revenue TTM 742.8m)
Net Margin = -11.58% (Net Income TTM -86.0m / Revenue TTM 742.8m)
Gross Margin = 55.89% ((Revenue TTM 742.8m - Cost of Revenue TTM 327.7m) / Revenue TTM)
Gross Margin QoQ = 57.78% (prev 56.06%)
Tobins Q-Ratio = 3.42 (Enterprise Value 4.29b / Total Assets 1.25b)
Interest Expense / Debt = 1.45% (Interest Expense 226.0k / Debt 15.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -65.2m (EBIT -82.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.49 (Total Current Assets 652.6m / Total Current Liabilities 145.3m)
Debt / Equity = 0.01 (Debt 15.5m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = 8.33 (negative EBITDA) (Net Debt -341.4m / EBITDA -41.0m)
Debt / FCF = -4.64 (Net Debt -341.4m / FCF TTM 73.6m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.88% (Net Income -86.0m / Total Assets 1.25b)
RoE = -8.04% (Net Income TTM -86.0m / Total Stockholder Equity 1.07b)
RoCE = -7.60% (EBIT -82.5m / Capital Employed (Equity 1.07b + L.T.Debt 15.5m))
RoIC = -6.09% (negative operating profit) (NOPAT -65.2m / Invested Capital 1.07b)
WACC = 12.65% (E(4.62b)/V(4.63b) * Re(12.69%) + D(15.5m)/V(4.63b) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 12.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.54%
[DCF Debug] Terminal Value 52.50% ; FCFF base≈73.6m ; Y1≈48.3m ; Y5≈22.0m
Fair Price DCF = 17.82 (EV 244.2m - Net Debt -341.4m = Equity 585.6m / Shares 32.9m; r=12.65% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -61.57 | EPS CAGR: -20.88% | SUE: 0.13 | # QB: 0
Revenue Correlation: -42.18 | Revenue CAGR: -0.34% | SUE: 0.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg30d=-0.000 | Revisions Net=+4 | Analysts=10
EPS next Year (2026-12-31): EPS=2.71 | Chg30d=+0.015 | Revisions Net=+1 | Growth EPS=+198.6% | Growth Revenue=+17.9%
P/S = 6.2145
P/B = 4.3144
P/EG = 3.0343
Revenue TTM = 742.8m USD
EBIT TTM = -82.5m USD
EBITDA TTM = -41.0m USD
Long Term Debt = 15.5m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = unknown (none)
Debt = 15.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -341.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.29b USD (4.62b + Debt 15.5m - CCE 341.4m)
Interest Coverage Ratio = -80.80 (Ebit TTM -82.5m / Interest Expense TTM 1.02m)
EV/FCF = 58.31x (Enterprise Value 4.29b / FCF TTM 73.6m)
FCF Yield = 1.72% (FCF TTM 73.6m / Enterprise Value 4.29b)
FCF Margin = 9.91% (FCF TTM 73.6m / Revenue TTM 742.8m)
Net Margin = -11.58% (Net Income TTM -86.0m / Revenue TTM 742.8m)
Gross Margin = 55.89% ((Revenue TTM 742.8m - Cost of Revenue TTM 327.7m) / Revenue TTM)
Gross Margin QoQ = 57.78% (prev 56.06%)
Tobins Q-Ratio = 3.42 (Enterprise Value 4.29b / Total Assets 1.25b)
Interest Expense / Debt = 1.45% (Interest Expense 226.0k / Debt 15.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -65.2m (EBIT -82.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.49 (Total Current Assets 652.6m / Total Current Liabilities 145.3m)
Debt / Equity = 0.01 (Debt 15.5m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = 8.33 (negative EBITDA) (Net Debt -341.4m / EBITDA -41.0m)
Debt / FCF = -4.64 (Net Debt -341.4m / FCF TTM 73.6m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.88% (Net Income -86.0m / Total Assets 1.25b)
RoE = -8.04% (Net Income TTM -86.0m / Total Stockholder Equity 1.07b)
RoCE = -7.60% (EBIT -82.5m / Capital Employed (Equity 1.07b + L.T.Debt 15.5m))
RoIC = -6.09% (negative operating profit) (NOPAT -65.2m / Invested Capital 1.07b)
WACC = 12.65% (E(4.62b)/V(4.63b) * Re(12.69%) + D(15.5m)/V(4.63b) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 12.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.54%
[DCF Debug] Terminal Value 52.50% ; FCFF base≈73.6m ; Y1≈48.3m ; Y5≈22.0m
Fair Price DCF = 17.82 (EV 244.2m - Net Debt -341.4m = Equity 585.6m / Shares 32.9m; r=12.65% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -61.57 | EPS CAGR: -20.88% | SUE: 0.13 | # QB: 0
Revenue Correlation: -42.18 | Revenue CAGR: -0.34% | SUE: 0.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg30d=-0.000 | Revisions Net=+4 | Analysts=10
EPS next Year (2026-12-31): EPS=2.71 | Chg30d=+0.015 | Revisions Net=+1 | Growth EPS=+198.6% | Growth Revenue=+17.9%